Search research articles
Contact Us
Filters
Showing results (151-160 of 272) with videos related to
Page
of 28
Sort By:
Scientific Reports
|
February 22, 2020
Phase I studies of vorinostat with ixazomib or pazopanib imply a role of antiangiogenesis-based therapy for TP53 mutant malignancies
Yudong Wang, Filip Janku, Sarina Piha-Paul, et al.
British Journal of Cancer
|
March 6, 2021
Phase 1 trial of ADI-PEG20 plus cisplatin in patients with pretreated metastatic melanoma or other advanced solid malignancies
Shuyang Yao, Filip Janku, Vivek Subbiah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 4, 2013
Weekly nab-Rapamycin in patients with advanced nonhematologic malignancies: final results of a phase I trial
Ana M Gonzalez-Angulo, Funda Meric-Bernstam, Sant Chawla, et al.
Frontiers in Chemistry
|
June 10, 2021
Chemical Composition, Antimicrobial and Insecticidal Activities of Essential Oils of Discarded Perfume Lemon and Leaves (<i>Citrus Limon</i> (L.) Burm. F.) as Possible Sources of Functional Botanical Agents
Panpan Wu, Xiaowen Tang, Rongchao Jian, et al.
Nature Medicine
|
July 27, 2023
Mesothelin-targeting T cell receptor fusion construct cell therapy in refractory solid tumors: phase 1/2 trial interim results
Raffit Hassan, Marcus Butler, Roisin E O'Cearbhaill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 24, 2009
Safety, pharmacokinetics, and antitumor activity of AMG 386, a selective angiopoietin inhibitor, in adult patients with advanced solid tumors
Roy S Herbst, David Hong, Linnea Chap, et al.
Gynecologic Oncology Research and Practice
|
May 28, 2016
Characteristics and outcomes for patients with advanced vaginal or vulvar cancer referred to a phase I clinical trials program: the MD Anderson cancer center experience
Siqing Fu, Naiyi Shi, Jennifer Wheler, et al.
Targeted Oncology
|
December 2, 2022
Phase I Study Evaluating Glesatinib (MGCD265), An Inhibitor of MET and AXL, in Patients with Non-small Cell Lung Cancer and Other Advanced Solid Tumors
Christian Kollmannsberger, Herbert Hurwitz, Lyudmila Bazhenova, et al.
AJNR. American Journal of Neuroradiology
|
February 20, 2026
Large Language Models for Accurate Medical Chart Abstraction: Enabling Scalable and Secure AI Deployment in Stroke
Zhusi Zhong, Carl M Porto, David Hong, et al.
The American Journal of Cardiology
|
February 16, 2019
Targeted Cancer Therapies With Pericardial Effusions Requiring Pericardiocentesis Focusing on Immune Checkpoint Inhibitors
Nicolas Palaskas, Jacob Morgan, Tina Daigle, et al.
Page
of 28
Search research articles
Search
Showing results (151-160 of 272) with videos related to
Sort By:
Page
of 28
Scientific Reports
|
February 22, 2020
Phase I studies of vorinostat with ixazomib or pazopanib imply a role of antiangiogenesis-based therapy for TP53 mutant malignancies
Yudong Wang, Filip Janku, Sarina Piha-Paul, et al.
British Journal of Cancer
|
March 6, 2021
Phase 1 trial of ADI-PEG20 plus cisplatin in patients with pretreated metastatic melanoma or other advanced solid malignancies
Shuyang Yao, Filip Janku, Vivek Subbiah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 4, 2013
Weekly nab-Rapamycin in patients with advanced nonhematologic malignancies: final results of a phase I trial
Ana M Gonzalez-Angulo, Funda Meric-Bernstam, Sant Chawla, et al.
Frontiers in Chemistry
|
June 10, 2021
Chemical Composition, Antimicrobial and Insecticidal Activities of Essential Oils of Discarded Perfume Lemon and Leaves (<i>Citrus Limon</i> (L.) Burm. F.) as Possible Sources of Functional Botanical Agents
Panpan Wu, Xiaowen Tang, Rongchao Jian, et al.
Nature Medicine
|
July 27, 2023
Mesothelin-targeting T cell receptor fusion construct cell therapy in refractory solid tumors: phase 1/2 trial interim results
Raffit Hassan, Marcus Butler, Roisin E O'Cearbhaill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 24, 2009
Safety, pharmacokinetics, and antitumor activity of AMG 386, a selective angiopoietin inhibitor, in adult patients with advanced solid tumors
Roy S Herbst, David Hong, Linnea Chap, et al.
Gynecologic Oncology Research and Practice
|
May 28, 2016
Characteristics and outcomes for patients with advanced vaginal or vulvar cancer referred to a phase I clinical trials program: the MD Anderson cancer center experience
Siqing Fu, Naiyi Shi, Jennifer Wheler, et al.
Targeted Oncology
|
December 2, 2022
Phase I Study Evaluating Glesatinib (MGCD265), An Inhibitor of MET and AXL, in Patients with Non-small Cell Lung Cancer and Other Advanced Solid Tumors
Christian Kollmannsberger, Herbert Hurwitz, Lyudmila Bazhenova, et al.
AJNR. American Journal of Neuroradiology
|
February 20, 2026
Large Language Models for Accurate Medical Chart Abstraction: Enabling Scalable and Secure AI Deployment in Stroke
Zhusi Zhong, Carl M Porto, David Hong, et al.
The American Journal of Cardiology
|
February 16, 2019
Targeted Cancer Therapies With Pericardial Effusions Requiring Pericardiocentesis Focusing on Immune Checkpoint Inhibitors
Nicolas Palaskas, Jacob Morgan, Tina Daigle, et al.
Page
of 28